Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA

McKeith, Ian G., Burn, David·2000·Neurologic Clinics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0733-8619(05)70230-9

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 71

  1. Aarsland, 1999, Donepezil for dementia with Lewy bodies: A case study, Int J Geriatr Psychiatr, 14, 69, 10.1002/(SICI)1099-1166(199901)14:1<69::AID-GPS888>3.0.CO;2-C · doi:10.1002/(sici)1099-1166(199901)14:1<69::aid-gps888>3.0.co;2-c
  2. Aarsland, 1999, Neuropsychiatric aspects of Parkinson's disease, Curr Psychiatr Rep, 1, 61, 10.1007/s11920-999-0011-3 · DOI
  3. Aarsland, 1999, Prevalence and clinical correlates of psychotic symptoms in Parkinson's disease: A community-based study, Arch Neurol, 56, 595, 10.1001/archneur.56.5.595 · DOI · Paper page
  4. Agid, 1994, Neuronal basis of mental impairment in parkinsonian syndromes, Behav Neurol, 7, 5
  5. Arai, 1994, Apolipoprotein E gene in Parkinson's disease with or without dementia, Lancet, 344, 889, 10.1016/S0140-6736(94)92862-2 · DOI
  6. Ayre, 1996, Psychological function in dementia with Lewy bodies and senile dementia of Alzheimer's type, Neurobiol Aging, 17, 205, 10.1016/S0197-4580(96)80207-7 · doi:10.1016/s0197-4580(96)80207-7
  7. Ballard, 1993, Idiopathic clouding of consciousness: Do the patients have cortical Lewy body disease?, Int J Geriatr Psychiatr, 8, 571, 10.1002/gps.930080707 · DOI
  8. Ballard, 2000, One year follow-up of parkinsonism in dementia with Lewy bodies, Dementia and Geriatric Cognitive Disorders, 11, 219, 10.1159/000017240 · DOI
  9. Ballard, 1998, A prospective study of dementia with Lewy bodies, Age Ageing, 27, 631, 10.1093/ageing/27.5.631 · DOI
  10. Barber, 1999, White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging, J Neurol Neurosurg Psychiatr, 67, 66, 10.1136/jnnp.67.1.66 · DOI · Paper page
  11. Birkett, 1992, Lewy bodies in psychiatric patients, Int J Geriatr Psychiatr, 7, 235, 10.1002/gps.930070404 · DOI
  12. Briel, 1999, EEG findings in dementia with Lewy bodies and Alzheimer's disease, J Neurol Neurosurg Psychiatr, 66, 401, 10.1136/jnnp.66.3.401 · DOI · Paper page
  13. Dickson, 1994, Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease, Acta Neuropathol, 87, 269, 10.1007/BF00296742 · DOI
  14. Gnanalingham, 1997, Motor and cognitive function in Lewy body dementia: Comparison with Alzheimer's and Parkinson's diseases, J Neurol Neurosurg Psychiatr, 62, 243, 10.1136/jnnp.62.3.243 · DOI · Paper page
  15. Goetz, 1998, Intravenous levodopa in hallucinating Parkinson's disease patients: High dose challenge does not precipitate hallucinations, Neurology, 50, 515, 10.1212/WNL.50.2.515 · DOI · Paper page
  16. Gomez-Tortosa, 1999, Clinical and quantitative pathological correlates of dementia with Lewy bodies, Neurology, 53, 1284, 10.1212/WNL.53.6.1284 · DOI · Paper page
  17. Haeske-Dewick, 1995, Hallucinations in Parkinson's disease: Characteristics and associated clinical features, Int J Geriatr Psychiatr, 10, 487, 10.1002/gps.930100608 · DOI
  18. Hansen, 1993, Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa, J Neuropathol Exp Neurol, 52, 648, 10.1097/00005072-199311000-00012 · DOI · Paper page
  19. Harrison, 1995, Senile dementia of Lewy body type: A review of clinical and pathological features: Implications for treatment, Int J Geriatr Psychiatr, 10, 919, 10.1002/gps.930101103 · DOI
  20. Hassler, 1938, Zur pathologie der paralysis agitans und des postenzephalitischen Parkinsonismus, J Psychologie Neurologie, 48, 387
  21. Higuchi, 1998, Diagnostic assessment and neuropathological correlates of cerebral metabolic changes in dementia with Lewy bodies: PET and postmortem brain studies, Neurobiol Aging, 19, S205
  22. Holmes, 1999, Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies, Br J Psychiatr, 174, 45, 10.1192/bjp.174.1.45 · DOI · Paper page
  23. Hutchinson, 1996, Cholinesterase inhibitors in Parkinson's disease, J Neurol Neurosurg Psychiatr, 61, 324, 10.1136/jnnp.61.3.324-a · DOI
  24. Iwanaga, 1999, Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases, Neurology, 52, 1269, 10.1212/WNL.52.6.1269 · DOI · Paper page
  25. Jellinger, 1996, Structural basis of dementia in neurodegenerative disorders, J Neural Transm, 47, 1, 10.1007/978-3-7091-6892-9_1 · DOI
  26. Jellinger, 1995, Structural basis of mental impairment in Parkinson's disease, Neuropsychiatrie, 9, 9
  27. Kaufer, 1998, Dementia with Lewy bodies: Response of delirium-like features to donepezil, Neurology, 51, 1512, 10.1212/WNL.51.5.1512 · DOI
  28. Klatka, 1996, Psychiatric features in diffuse Lewy body disease: Findings in 28 pathologically diagnosed cases, Neurology, 46, A180
  29. Kosaka, 1998, Recent advances in dementia research in Japan: Non-Alzheimer type degenerative dementias, Psychiatr Clin Neurosci, 52, 367, 10.1046/j.1440-1819.1998.00402.x · DOI
  30. Kosaka, 1984, Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: A new disease?, Clin Neuropathol, 3, 185
  31. Kuzuhara, 1993, Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly, Adv Neurol, 60, 464
  32. Lennox, 1989, Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry, J Neurol Neurosurg Psychiatr, 52, 1236, 10.1136/jnnp.52.11.1236 · DOI · Paper page
  33. Litvan, 1998, Accuracy of the clinical diagnoses of Lewy body disease, Parkinson's disease, and dementia with Lewy bodies, Arch Neurol, 55, 969, 10.1001/archneur.55.7.969 · DOI · Paper page
  34. Louis, 1997, Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease, Neurology, 48, 376, 10.1212/WNL.48.2.376 · DOI · Paper page
  35. Luis, 1999, Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample, Int J Geriatr Psychiatr, 14, 526, 10.1002/(SICI)1099-1166(199907)14:7<526::AID-GPS965>3.0.CO;2-0 · DOI
  36. McKeith, 1992, Neuroleptic sensitivity in patients with senile dementia of Lewy body type, Br Med J, 305, 673, 10.1136/bmj.305.6855.673 · DOI · Paper page
  37. McKeith, 1998, Dementia with Lewy bodies: Clinical and pathological diagnosis, Alzheimer Rep, 1, 83
  38. McKeith, 1995, Neuroleptic sensitivity to risperidone in Lewy body dementia, Lancet, 346, 699, 10.1016/S0140-6736(95)92307-1 · DOI
  39. McKeith, 2000, Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies, Neurology, 54, 1050, 10.1212/WNL.54.5.1050 · DOI · Paper page
  40. McKeith, 2000, Rivastigmine in the treatment of dementia with Lewy bodies, Int J Geriatr Psychiatr, 15, 387, 10.1002/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9 · doi:10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9
  41. McKeith, 1996, Apolipoprotein E genotyping in Alzheimer's disease, Lancet, 347, 1775, 10.1016/S0140-6736(96)90857-0 · DOI
  42. McKeith, 1999, Diagnosing dementia with Lewy bodies, Lancet, 354, 1227, 10.1016/S0140-6736(99)90214-3 · DOI
  43. McKeith, 1999, Report of the second dementia with Lewy body international workshop, Neurology, 53, 902, 10.1212/WNL.53.5.902 · DOI · Paper page
  44. McKeith, 1992, Operational criteria for senile dementia of Lewy body type (SDLT), Psychol Med, 22, 911, 10.1017/S0033291700038484 · DOI · Paper page
  45. McShane, 1995, Prospective study of relations between cortical Lewy bodies, poor eyesight and hallucinations in Alzheimer's disease, J Neurol Neurosurg Psychiatr, 59, 185, 10.1136/jnnp.59.2.185 · DOI
  46. McShane, 1998, Prospective evaluation of diagnostic criteria for dementia with Lewy bodies, Neurobiol Aging, 19, S204
  47. Mega, 1996, Dementia with Lewy bodies: Reliability and validity of clinical and pathologic criteria, Neurology, 47, 1403, 10.1212/WNL.47.6.1403 · DOI · Paper page
  48. Merello, 1994, Extrapyramidisation in Alzheimer's disease: Prevalence, psychiatric and neuropsychological correlates, J Neurol Neurosurg Psychiatr, 57, 1503, 10.1136/jnnp.57.12.1503 · DOI
  49. Morris, 1996, Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias, J Neural Transm, 47, 205, 10.1007/978-3-7091-6892-9_14 · DOI
  50. Naimark, 1996, Psychotic symptoms in Parkinson's disease patients with dementia, J Am Geriatr Soc, 44, 296, 10.1111/j.1532-5415.1996.tb00918.x · DOI
  51. O'Brien, 1998, Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease, Neurobiol Aging, 19, S205
  52. Okazaki, 1961, Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadrapesis in flexion, J Neurol Neurosurg Psychiatr, 20, 237
  53. Papka, 1998, Diagnosing Lewy body disease: Accuracy of clinical criteria in detecting Lewy body pathology, Neurobiol Aging, 19, S203
  54. Pappert, 1999, Hallucinations, sleep fragmentation, and altered dream phenomenon in Parkinson's disease, Mov Disord, 14, 117, 10.1002/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0 · DOI · Paper page
  55. Perry, 1993, Cholinergic transmitter and neurotrophic activities in Lewy body dementia: Similarity to Parkinson's and distinction from Alzheimer's disease, Alzheimer Dis Assoc Disord, 7, 69, 10.1097/00002093-199307020-00002 · DOI · Paper page
  56. Perry, 1990, Evidence of monaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia, J Neurochem, 55, 1454, 10.1111/j.1471-4159.1990.tb03162.x · DOI · Paper page
  57. Piggott, 1999, Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution, Brain, 122, 1449, 10.1093/brain/122.8.1449 · DOI · Paper page
  58. Piggott, 1994, Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity, Lancet, 343, 1044
  59. Rodriguez-Fernandez, 1998, Regional cerebral blood flow in patients with dementia with Lewy bodies, Neurobiol Aging, 19, S205
  60. Sahgal, 1992, A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types, Dementia, 3, 350
  61. Samuel, 1996, Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease, J Neuropathol Exp Neurol, 55, 44, 10.1097/00005072-199601000-00005 · DOI
  62. Shea, 1998, Donepezil for treatment of dementia with Lewy bodies: A case series of nine patients, Int Psychogeriatrics, 10, 229, 10.1017/S1041610298005341 · DOI · Paper page
  63. The Parkinson's Disease Study Group, 1999, Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease, New Engl J Med, 340, 757, 10.1056/NEJM199903113401003 · DOI · Paper page
  64. Trojanowski, 1998, Dementia with Lewy bodies: Histochemical aspects of differential diagnosis, Neurobiol Aging, 19, S4
  65. Walker, 2000, Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease and vascular dementia, Neurology, 54, 1616, 10.1212/WNL.54.8.1616 · DOI · Paper page
  66. Walker, 1997, Neuropsychological performance in Lewy body dementia and Alzheimer's disease, Br J Psychiatr, 170, 156, 10.1192/bjp.170.2.156 · DOI
  67. Walker, 1999, In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies, Lancet, 354, 646, 10.1016/S0140-6736(99)01178-2 · DOI
  68. Walker, 1999, Olanzapine in dementia with Lewy bodies: A clinical study, Int J Geriatr Psychiatr, 14, 459, 10.1002/(SICI)1099-1166(199906)14:6<459::AID-GPS957>3.0.CO;2-R · DOI
  69. Wolters, 1996, Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease, Neurology, 47, 1085, 10.1212/WNL.47.4.1085 · DOI · Paper page
  70. Woodard, 1962, Concentric hyaline inclusion body formation in mental disease: Analysis of twenty-seven cases, J Neuropathol Exp Neurol, 21, 442, 10.1097/00005072-196207000-00012 · DOI
  71. Zoldan, 1993, Ondansetron for hallucinosis in advanced Parkinson's disease, Lancet, 341, 562, 10.1016/0140-6736(93)90327-D · DOI

Cited by

See all 168

Metadata

Authors
McKeith, I. G., & Burn, D.
Venue
Neurologic Clinics
Publisher
Elsevier BV
Published
2000-11
Volume
18
Issue
4
Pages
865-883
ISSN
0733-8619 (ISSN-L)
OpenAlex
W2029315819
Cited by
168
References
3
FWCI
4.70
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA. https://app.cochat.ai/papers/10.1016/s0733-8619(05)70230-9
The paper
McKeith, I. G., & Burn, D. (2000). SPECTRUM OF PARKINSON'S DISEASE, PARKINSON'S DEMENTIA, AND LEWY BODY DEMENTIA. Neurologic Clinics. https://doi.org/10.1016/s0733-8619(05)70230-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.